Remove 2001 Remove Packaging Remove Regulations Remove Trials
article thumbnail

Where is the promise for plant-based medicines? Part 2: Psilocybin 

Drug Discovery World

Of course, while the regulation remains a continuous battle, this does not hinder the research being undertaken. However, the substance has shown promise in the field of medicine for a range of diseases and conditions, making its legality a debating point within the drug discovery industry internationally.

article thumbnail

Analysis Life Sciences Thank You The cost of artificially short expiration dates: Worsened shortages, higher costs and more waste

Agency IQ

Though regulations guide some aspects of how expiration dates are determined, the agency has but limited power to extend those dates unilaterally. As part of current good manufacturing practice (cGMP) regulations, drugs are required to bear an expiration date determined by “appropriate stability testing,” according to 21 CFR 211.137.

Science 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article FDA Thank You FDA updates set the stage for broader use of harmonized standards for safety reporting

Agency IQ

FDA updates set the stage for broader use of harmonized standards for safety reporting Though long considered a top priority by regulators, the process to standardize and harmonize the submission of individual case safety reports (ICSRs) has been slow. Periodic Benefit-Risk Evaluation Reports ).

FDA 40
article thumbnail

How the Fifty States View Electronic Data as a “Product”

Drug & Device Law

2003), an Internal Revenue Service regulation, excluded liability for “product” refund, repair or replacement. 2001); Isham v. 2001), relied on these other statutes to hold that a road could not be a “product”). A Florida trial court, in Brookes v. at 77 (citation omitted). In United States v. Brown , 348 F.3d